REVIEW OF TALAROMYCOSIS IN HIV/AIDS PATIENT

Triều Lý Võ 1,, Minh Nhựt Vương1, Thuỳ Lê2
1 University of Medicine and Pharmacy at Ho Chi Minh City
2 Duke University, USA

Main Article Content

Abstract

Objective: Summarize the literature in the world and in Vietnam on the epidemiological, clinical, and laboratory characteristics and treatment of Talaromycosis in HIV/AIDS patients in order to improve the effectiveness, diagnosis and treatment. Methods: Search and analyze the literature related to clinical symptoms, diagnostic tests, and treatment of Talaromycosis infection. Result: Talaromycosis is a common opportunistic infection in HIV/AIDS patients with TCD4+ counts <100 cells/mm3, especially in Southeast Asia with mortality rates ranging from 5 to 30 %, mainly due to late diagnosis. Common manifestations of the disease are fever, liver, spleen enlargement and skin papules. The current diagnosis is based on conventional microbiological culture methods; Serological tests promise to shorten the time to diagnosis. Current treatment is based on the use of amphotercin B or itraconazole. Conclusion and recommendations: Research new test to improve the diagnostic time.

Article Details

References

1. Bộ Y tế, Hướng dẫn điều trị và chăm sóc HIV/AIDS, 2021, Quyết định số 5968/QĐ-BYT ngày 31/12/2021 của Bộ Y tế: Hà Nội.
2. Võ Triều Lý, Nguyễn Văn Vĩnh Châu, Cao Ngọc Nga, Nguyễn Thị Mai Thu, Nguyễn Tất Thành, et al., "Giá trị xét nghiệm Mp1p ELISA trong chẩn đoán sớm nhiễm nấm Talaromyces marneffei ở bệnh nhân HIV/AIDS". Tạp chí Y học Thành phố Hồ Chí Minh, 2021,25 (1), pp.122-127.
3. AIDSinfo. "Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents ". U.S. Department of Health and Human Services, 2022, pp. 1-432.
4. Hien H. T. A., Thanh T. T., Thu N. T. M., Nguyen A., Thanh N. T., et al., "Development and evaluation of a real-time polymerase chain reaction assay for the rapid detection of Talaromyces marneffei MP1 gene in human plasma". Mycoses, 2016, 59 (12), pp. 773-780.
5. Larsson M., Nguyen L. H., Wertheim H. F., Dao T. T., Taylor W., et al., "Clinical characteristics and outcome of Penicillium marneffei infection among HIV-infected patients in northern Vietnam". AIDS Res Ther, 2012, 9 (1), pp. 24.
6. Thuy Le Marcel Wolbers, Nguyen Huu Chi, Vo Minh Quang,2 Nguyen Tran Chinh, Nguyen Phu Huong Lan, Pham Si Lam, Michael J. Kozal, Cecilia M. Shikuma, Jeremy N. Day and Jeremy Farrar, "Epidemiology, Seasonality, and Predictors of Outcome of AIDS-Associated Penicillium marneffei Infection in Ho Chi Minh City, Viet Nam". Clin Infect Dis, 2011, 52 (7), pp. 945-952.
7. V.T. Son. P.M. Khue., M. Strobel., "Penicilliosis and AIDS in Haiphong, Vietnam: Evolution and predictive factors of death". Médecine et maladies infectieuses 44 (2014) 495–501, 2014.
8. Thu NTM, Chan JFW, Hien HTA, Tung NLN, Thanh NT, et al., Clinical Performance of the Mp1p Immunoassay for Rapid Diagnosis of Talaromyces marneffei Infection, in Conference of Retroviruses and Opportunistic Infections Feb 13-16, 2017: Seattle, WA, USA